Study of Leukocyte Immunophenotype and the Lipid Transport System as Predictive Biomarkers of Severe Bacterial Infections
Launched by THE REPUBLICAN RESEARCH AND PRACTICAL CENTER FOR EPIDEMIOLOGY AND MICROBIOLOGY · Nov 24, 2019
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
* To study the state of the immune system in patients with severe bacterial infections (on the model of pneumonia, infective endocarditis, sepsis): spontaneous and stimulated production of reactive oxygen species by blood neutrophils; spontaneous necroptosis, apoptosis and pyroptosis of neutrophils; the content of blood leukocyte subpopulations.
* Assess the clinical, biochemical status, state of the lipid transport system of patients with severe bacterial infections (in the model of pneumonia, infective endocarditis, sepsis), including determination of the cholesterol content in the cell m...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • community-acquired pneumonia, severe course (according to IDSA / ATs criteria) and / or sepsis with different localization of the primary focus (SOFA\> 2);
- • the patient's ability to comply with the instructions of the research doctor and follow the procedures required by the test protocol;
- • informed consent.
- Exclusion Criteria:
- • acute and chronic heart failure;
- • renal failure;
- • acute and chronic liver failure;
- • taking medications of the statin group during the last month before the study;
- • diabetes in the stage of clinical and metabolic decompensation;
- • acute and chronic leukemia, severe anemia;
- • pregnancy or lactation;
- • HIV infection;
- • drug addiction;
- • immunosuppressive therapy;
- • malignant neoplasms over the past 5 years.
About The Republican Research And Practical Center For Epidemiology And Microbiology
The Republican Research and Practical Center for Epidemiology and Microbiology is a leading institution dedicated to advancing public health through rigorous scientific research and practical applications in the fields of epidemiology and microbiology. With a focus on understanding disease patterns and developing innovative solutions to combat infectious diseases, the center collaborates with national and international partners to conduct clinical trials that contribute to evidence-based practices and policies. Its commitment to enhancing health outcomes is reflected in its comprehensive research initiatives, which aim to improve disease prevention, control strategies, and overall public health resilience.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minsk, , Belarus
Patients applied
Trial Officials
Elena Fomina, Dr
Principal Investigator
Head of the laboratory, RSPCEM
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials